News Molecular Partners AG

Equities

MOLN

CH0256379097

Real-time Estimate Cboe Europe Other stock markets 10:15:06 2024-04-16 am EDT			5-day change	1st Jan Change
3.483 ^CHF	-2.57%		-0.73%	-0.87%

Mar. 15	Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024
Mar. 15	Molecular Partners Swings to Loss in FY23; Revenue Down	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	Apr. 01	AQ
Molecular Partners Publishes Invitation to Annual General Meeting 2024	Mar. 26	GL
Molecular Partners Publishes Invitation to Annual General Meeting 2024	Mar. 26	AQ
Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024	Mar. 15
Molecular Partners Swings to Loss in FY23; Revenue Down	Mar. 15	MT
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023	Mar. 14	GL
Molecular Partners AG Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
US Court Dismisses Putative Class Action Against Molecular Partners	Mar. 03	MT
Molecular Partners Announces Dismissal of Class Action Lawsuit	Mar. 01	GL
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations	Mar. 01	GL
Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations	Mar. 01	AQ
Transcript : Molecular Partners AG Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 10:30 AM	Jan. 10
Molecular Partners Gears Up for 2024 Milestones, Including Data From Leukemia Treatment Trial	Jan. 08	MT
Molecular Partners, Orano Med Team Up to Develop Radio-DARPin Therapeutics Against Cancer	Jan. 08	MT
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 07	AQ
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies	Jan. 05	AQ
Molecular Partners AG and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies	Jan. 05	CI
Novocure Names Nicolas Leupin as Chief Medical Officer	Jan. 04	MT
ADRs Advance; Boqii Holding Ltd. Climbs 16.2%	Jan. 04	DJ
ADRs Hold Steady; TDCX Inc. Climbs 30.4%	Jan. 03	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Molecular Partners AG

Equities

MOLN

CH0256379097

Summary

Filters